Sharmista Chatterjee
Sharmista Chatterjee is acting branch I chief/division 1 of process assessment/Office of Process and Facilities, at the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, FDA.
Articles
Flowsheet Models Modernize Pharmaceutical Manufacturing Design and Risk Assessment
Fernando Muzzio, PhD;Marianthi Ierapetritou;Ravendra Singh;Rohit Ramachandran;M. Sebastian Escotet-Espinoza;Sharmista Chatterjee;Thomas O’Connor;Sau Lee;Maitraye Sen
April 2nd 2015In-silico design facilitates process optimization and evaluation of process control strategies.
Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 6th 2024 | Updated: November 20th 2024
Automate Aseptic Filling: Closing the System at Full Modularity
Published: November 5th 2024 | Updated: November 20th 2024
Untethered Data: Unifying and Contextualizing Drug Discovery Data
Published: November 8th 2024 | Updated: November 20th 2024
Application of Validation Principles to the Training Quality System: Part 9, Quality Risk Management Hazard Identification
Published: November 4th 2024 | Updated: November 20th 2024
Strategies for Overcoming Common Challenges in Tech Transfer
